Non-alcoholic fatty liver disease (NAFLD) and mortality

Journal of Hepatology

Volumn 51, Issue 3, 2009, Pages 593-

  Ruhl, Constance E ^a   Everhart, James E ^b  

^a SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; HUMAN; LETTER; MORTALITY; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; FATTY LIVER; HUMANS; NUTRITION SURVEYS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; UNITED STATES;

EID: 68049135720     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.05.010     Document Type: Letter

References (3)

1. Ong J.P., Pitts A., and Younossi Z.M. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol 49 (2008) 608-612
2. Ruhl C.E., and Everhart J.E. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 136 (2009) 477-485 e11
3. National Center for Health Statistics (NCHS). Analytic and reporting guidelines: the third national health and nutrition examination survey, NHANES III (1988-94). Hyattsville, MD: NCHS; 1996. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes3/nh3gui.pdf (cited 30 March 2009).